Klow

Name: Klow
Brand: Klow
SKU: PEP-KLOW-80-003
Availability: InStock

KLOW is a research-grade, synergistic multi-peptide blend formulated for advanced laboratory investigation into tissue repair, inflammation signaling, and cellular regeneration . This combination is often referred to as the “KLOW Stack” within scientific communities, representing a next-generation formulation that builds upon classic peptide blends.

This lyophilized powder combines four well-characterized peptides—GHK-Cu, BPC-157, TB-500 (Thymosin Beta-4), and KPV—in precise, pre-measured proportions to ensure experimental consistency . Each 80 mg vial is designed exclusively for in vitro and preclinical research applications, allowing scientists to study peptide synergy across multiple biological pathways simultaneously.

The KLOW formulation is strictly intended for laboratory research only and is not approved for human or veterinary use.

Key Features

Synergistic Quad-Blend: Combines GHK-Cu, BPC-157, TB-500, and KPV in a single vial
High Purity: Verified by independent third-party HPLC analysis (≥99% purity)
Research-Grade Formulation: Precise ratio of 70/10/10/10 (GHK-Cu / BPC-157 / TB-500 / KPV)
Tamper-Evident Sealing: Nitrogen-sealed, sterile vials for secure transport
Certified Testing: Batch-specific lab reports available for quality transparency

Specifications

Specification	Detail
Total Mass	80 mg per vial
Composition	GHK-Cu (70%), BPC-157 (10%), TB-500 (10%), KPV (10%)
Purity	≥99% (Third-Party HPLC Verified)
Appearance	White lyophilized powder
Storage (Lyophilized)	-20°C, protected from light and moisture
Storage (Reconstituted)	2-8°C (refrigerate), use within 14-28 days
CAS Numbers	946870-92-4, 77591-33-4, 67727-97-3, 49557-75-7

Research Applications

KLOW is designed for preclinical research investigating multi-pathway interventions, including:

Tissue Repair & Remodeling: Studying collagen synthesis, angiogenesis, and extracellular matrix organization
Inflammation Modulation: Exploring NF-κB signaling and cytokine regulation via KPV and BPC-157
Wound Healing Models: Investigating actin-mediated cell migration and granulation tissue formation
Musculoskeletal Recovery: Evaluating tendon, ligament, and muscle healing in controlled models

Reconstitution & Dosage Guidelines (Research Use Only)

Parameter	Recommendation
Reconstitution Volume	Add 3.0 mL bacteriostatic water
Final Concentration	~26.7 mg/mL total (GHK-Cu: ~16.7 mg/mL; others: ~3.33 mg/mL)
Dosing Range (Research)	7.5–22.5 units daily on U-100 syringe
Cycle Length	8–16 weeks depending on study design

Note: These are educational references for laboratory protocol design, not medical dosing instructions.

Quality Assurance

This KLOW product undergoes rigorous quality control, including:

Independent Lab Testing: Janoshik Analytical verification of mass and composition
Batch Tracking: Each unit is batch-coded with publicly accessible Certificates of Analysis
Sterility Assurance: RTF vials are washed, depyrogenated, and ETO sterilized